Perpetua Medical AB (OSTO:PERP B) Piotroski F-Score: 4 (As of Sep. 08, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:PERP B Perpetua Medical AB OSTO:PERP B
53 GF Score
Price kr2.82
GF Value kr3.93
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Perpetua Medical AB Piotroski F-Score?

Perpetua Medical AB OSTO:PERP B +2.55% 53 Piotroski F-Score is 4 as of Sep. 08, 2026, which is at its 10-year median of 4.00. GuruFocus rates OSTO:PERP B with a GF Score™ of 53/100 and a GF Value™ of kr3.93 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Perpetua Medical AB ranks worse than 57.79% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Perpetua Medical AB has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Perpetua Medical AB's Piotroski F-Score or its related term are showing as below:

OSTO:PERP B' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 6
Current: 4

During the past 12 years, the highest Piotroski F-Score of Perpetua Medical AB was 6. The lowest was 2. And the median was 4.

Perpetua Medical AB  (OSTO:PERP B) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Perpetua Medical AB Piotroski F-Score Related Terms


Perpetua Medical AB Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Perpetua Medical AB's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perpetua Medical AB Piotroski F-Score Chart

Perpetua Medical AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 2.00 3.00 5.00 5.00

Perpetua Medical AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 5.00 5.00 6.00 4.00

OSTO:PERP B vs ABT, SYK, MDT: Piotroski F-Score Comparison

For the Medical Devices subindustry, Perpetua Medical AB's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Perpetua Medical AB Piotroski F-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Perpetua Medical AB's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Perpetua Medical AB's Piotroski F-Score falls into.


OSTO:PERP B
53GF Score
Perpetua Medical AB OSTO:PERP B
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun26) TTM:Last Year (Jun25) TTM:
Net Income was 7.442 + -2.862 + -2.067 + -2.174 = kr0.34 Mil.
Cash Flow from Operations was -1.015 + -1.393 + -2.032 + -1.866 = kr-6.31 Mil.
Revenue was 3.477 + 5.157 + 4.981 + 5.963 = kr19.58 Mil.
Gross Profit was 1.654 + 2.729 + 2.632 + 2.518 = kr9.53 Mil.
Average Total Assets from the begining of this year (Jun25)
to the end of this year (Jun26) was
(16.114 + 46.721 + 43.539 + 58.98 + 58.131) / 5 = kr44.697 Mil.
Total Assets at the begining of this year (Jun25) was kr16.11 Mil.
Long-Term Debt & Capital Lease Obligation was kr0.00 Mil.
Total Current Assets was kr33.10 Mil.
Total Current Liabilities was kr8.80 Mil.
Net Income was -1.125 + -1.356 + -1.314 + -0.814 = kr-4.61 Mil.

Revenue was 0.385 + 4.164 + 3.227 + 2.7 = kr10.48 Mil.
Gross Profit was -0.051 + 1.978 + 1.499 + 1.72 = kr5.15 Mil.
Average Total Assets from the begining of last year (Jun24)
to the end of last year (Jun25) was
(12.036 + 20.346 + 18.745 + 17.45 + 16.114) / 5 = kr16.9382 Mil.
Total Assets at the begining of last year (Jun24) was kr12.04 Mil.
Long-Term Debt & Capital Lease Obligation was kr4.00 Mil.
Total Current Assets was kr10.51 Mil.
Total Current Liabilities was kr2.66 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Perpetua Medical AB's current Net Income (TTM) was 0.34. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Perpetua Medical AB's current Cash Flow from Operations (TTM) was -6.31. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun25)
=0.339/16.114
=0.02103761

ROA (Last Year)=Net Income/Total Assets (Jun24)
=-4.609/12.036
=-0.38293453

Perpetua Medical AB's return on assets of this year was 0.02103761. Perpetua Medical AB's return on assets of last year was -0.38293453. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Perpetua Medical AB's current Net Income (TTM) was 0.34. Perpetua Medical AB's current Cash Flow from Operations (TTM) was -6.31. ==> -6.31 <= 0.34 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun25 to Jun26
=0/44.697
=0

Gearing (Last Year: Jun25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun24 to Jun25
=4/16.9382
=0.2361526

Perpetua Medical AB's gearing of this year was 0. Perpetua Medical AB's gearing of last year was 0.2361526. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun26)=Total Current Assets/Total Current Liabilities
=33.096/8.795
=3.76304719

Current Ratio (Last Year: Jun25)=Total Current Assets/Total Current Liabilities
=10.505/2.658
=3.95221971

Perpetua Medical AB's current ratio of this year was 3.76304719. Perpetua Medical AB's current ratio of last year was 3.95221971. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Perpetua Medical AB's number of shares in issue this year was 8.557. Perpetua Medical AB's number of shares in issue last year was 4.522. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=9.533/19.578
=0.4869241

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=5.146/10.476
=0.49121802

Perpetua Medical AB's gross margin of this year was 0.4869241. Perpetua Medical AB's gross margin of last year was 0.49121802. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun25)
=19.578/16.114
=1.21496835

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun24)
=10.476/12.036
=0.87038883

Perpetua Medical AB's asset turnover of this year was 1.21496835. Perpetua Medical AB's asset turnover of last year was 0.87038883. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+0+1+0+1+0+0+0+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Perpetua Medical AB has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 4 mean?
Perpetua Medical AB (OSTO:PERP B) has a Piotroski F-Score of 4 as of Sep. 08, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Perpetua Medical AB and its competitors. This is near median its historical median of 4.00. Over the past decade, Perpetua Medical AB's Piotroski F-Score has ranged from 2.00 to 6.00. According to the industry distribution chart, Perpetua Medical AB ranks #471 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 57.8%.
Is Perpetua Medical AB's Piotroski F-Score too high?
Perpetua Medical AB's current Piotroski F-Score of 4 is near median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 6.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. Perpetua Medical AB's value of 4 is 20% below this industry median. Based on the distribution chart, Perpetua Medical AB ranks #471 out of 815 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Perpetua Medical AB has a GF Score™ of 53/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Perpetua Medical AB's Piotroski F-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Perpetua Medical AB ranks #471 out of 815 companies for Piotroski F-Score. This places Perpetua Medical AB in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Perpetua Medical AB's value of 4 is 20% below this benchmark. Historically, Perpetua Medical AB's own Piotroski F-Score has ranged from 2.00 to 6.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, Perpetua Medical AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Perpetua Medical AB's current Piotroski F-Score of 4 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Perpetua Medical AB and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Perpetua Medical AB's current Piotroski F-Score is 4, which is near median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perpetua Medical AB stock overvalued right now?
Based on GuruFocus' analysis, Perpetua Medical AB (OSTO:PERP B) is currently considered Modestly Undervalued. The stock's GF Value™ is kr3.93, compared to a current price of kr2.82 — trading 28.2% below its estimated fair value. The current Piotroski F-Score is 4, which is near median its 10-year median of 4.00 and 20% below the Medical Devices & Instruments industry median of 5.00. Perpetua Medical AB's overall GF Score™ is 53/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Perpetua Medical AB (OSTO:PERP B), the current Piotroski F-Score is 4 as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Perpetua Medical AB (OSTO:PERP B) Overvalued in 2026?

Based on GuruFocus' analysis, Perpetua Medical AB stock appears to be undervalued. The current stock price of kr2.82 is trading 28.2% below its estimated GF Value™ of kr3.93. GuruFocus considers Perpetua Medical AB to be Modestly Undervalued.

Key valuation signals for OSTO:PERP B:

  • Piotroski F-Score: 4 (near median its 10-year median of 4.00)
  • GF Value™: kr3.93 vs. price of kr2.82 (28.2% below fair value)
  • GF Score™: 53/100 with 5 warning signs
  • Industry Position: 20% below the Medical Devices & Instruments median (#471 of 815)

No single metric tells the full story. See the OSTO:PERP B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Perpetua Medical AB Business Description

Address Ekeby Bruk 2H, Uppsala, SWE, SE-752 63
Perpetua Medical AB is engaged in healthcare sector. The company develops systems and solutions that plan to optimize and ensure correct and effective treatment with injectable drugs. Its products include WasteLog and Pharmacolog Dashboard.
53GF Score

Get the complete analysis for OSTO:PERP B

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.82
Price
kr3.93
GF Value